Form 4: Replimune Group Executive Christopher Sarchi Reports Stock and Option Transactions
SEC Form 4
Christopher Sarchi, Chief Commercial Officer of Replimune Group, reports acquisition of stock and stock options.
Summary
- Christopher Sarchi, Chief Commercial Officer of Replimune Group, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On April 1, 2024, Sarchi acquired 22,225 shares of common stock through the settlement of restricted stock units (RSUs) at $0.
- Following this transaction, Sarchi directly owns 94,470 shares of Replimune Group, Inc.
- Additionally, on the same date, Sarchi acquired options to purchase 66,675 shares of common stock at an exercise price of $7.73, which vest over time.
- These options expire on April 1, 2034.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of executive stock transactions.
Positives
- The acquisition of shares and options by a key executive could be seen as a positive sign of confidence in the company's future.
Future Outlook
The vesting schedules for both the RSUs and stock options indicate a long-term commitment from the executive to the company's success.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.
Stakeholder Impact
- The transactions may influence investor perception of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
| 04/01/2025 | 25% of the shares underlying the stock option vest. |
| 05/15/2025 | 25% of the RSUs will vest. |
| 05/15/2028 | Final vesting date for the RSUs. |
| 04/01/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.